Ukulunywa omiyane kungabi ukucasuka kuphela, kodwa futhi kuyingozi ngqo, njengoba lawa amahlumela ethwala izifo eziningi eziyingozi kubantu. Ososayensi bomhlaba wonke bafuna imali ukuxazulula inkinga, bezama ukukhiqiza ngisho nezinambuzane ze-GM kwintando - kuze kube manje ngempumelelo ehlukahlukene. Kukhathazekile ngokuphathwa kwamaphrojekthi ocwaningo othembisayo we-American Ministry of Defense (DARPA), okusetshenziselwa ukubuyela emuva kohlelo lokudala izimpendulo ezintsha ezisebenzayo.
Enye yamaphrojekthi alolu hlelo kwaba yi- "Live Biotheripeutic Product, LBP), ososayensi abavela eFlorida International University, izinkampani ze-Azitra Pharmacological kanye noLatham BioParm baqala umsebenzi. Uhola ama-Consortium Biotechnology StartUp Ginkgo Bioworks, athole ama- $ 15 wezigidi zale misebenzi. I-LBP - ayiphenduli ngomqondo ojwayelekile weZwi; Ayethusa amagazi, kepha umane wehlise ukuheha kwabo ngephunga lomuntu, eshintsha ukwakheka kwe-microflora yesikhumba.
Eqinisweni, isikhumba sethu siphephela njengesiphephelo samagciwane ahlukahlukene acwebezelayo adla ukukhishwa kwamafutha namaseli afile. Kungumsebenzi wabo oholela ekubonakaleni kwezinto eziguqukayo ezakha iphunga lesici sokujuluka. Ngakho-ke, abathuthukisi bakhulelwa ukuxazulula isikhumba esakha ngokukhethekile izingqinamba ze-GM ezingeke ziveze amakhompiyutha aheha omiyane. Ngokusho kwabo, ukwelashwa okunjalo kuzovikela umuntu ekulumeleni ngasikhathi sinye amasonto amabili.
Ngenkathi iphrojekthi ibukeka ingelinye iphuzu ochungechungeni olude lwemibono emihle, eyazama ukusebenzisa i-DARPA. Uma kuphela ngoba i-microflora yomuntu ngamunye ingumuntu ngamunye, - futhi kuyini ukusabela kubantu bezindawo zokuhlanza isikhumba ecaleni ngalinye, kunzima ukubikezela. Noma kunjalo, kwi-akhawunti ye-DARPA - isisindo futhi sisebenze ngempumelelo ubuchwepheshe. Ngakho-ke kufanelekile ukulinda imiphumela yohlelo lokubuyisela emuva, enzelwe iminyaka emine.
Umthombo: Isayensi Enqunu